PhuturdexDrug Pipeline Intelligence

Phuturdex › Drugs › Acetaminophen

Drugs in development · updated 30 October 2026

Acetaminophen: clinical trials and development status

Other names and codes: Paracetamol, APAP, Tylenol, Ofirmev, Infants' Feverall, Acephen

NLM verified identityApproved in the US (FDA)

As of 30 October 2026 Acetaminophen is in 57 active clinical trials (recruiting or ongoing, phases I–III) for 38 diseases. The most advanced phase is III.

57Active trials
IIIMost advanced phase
38Diseases studied

Summary updated every week · data as of 30 October 2026. In Phuturdex you can follow Acetaminophen and get an email at every change or safety alert.

Sign in free →

Diseases studied

For each disease: the drug’s most advanced phase and active trials, with the reference trial on ClinicalTrials.gov. Showing 30 of 38 diseases.

DiseaseMost advanced phaseActive trialsReference trial
Multiple myelomaIII5NCT03823534
AgnosiaIII3NCT06994442
Lupus nephritisIII3NCT04221477
Postoperative painIII3NCT07225140
Ovarian neoplasmIII2NCT06824467
Systemic lupus erythematosusIII2NCT04963296
Burkitt lymphomaII–III1NCT07570173
Chronic progressive multiple sclerosisIII1NCT04688788
Emergence deliriumII–III1NCT06653465
Fallopian tube neoplasmIII1NCT06824467
HeadacheIII1NCT06861738
LymphomaIII1NCT03823534
Non-small-cell lung carcinomaIII1NCT06305754
PainIII1NCT03823534
Relapsing-remitting multiple sclerosisIII1NCT04688788
Chronic lymphocytic leukemiaII2NCT07709000
Hairy cell leukemiaII2NCT01059786
Acute painII1NCT07807644
B-cell leukemiaII1NCT07709000
Crohn's diseaseI–II1NCT04224558
Esophageal neoplasmI–II1NCT05319730
Esophageal squamous cell carcinomaI–II1NCT05319730
Follicular lymphomaII1NCT06043323
Hematologic neoplasmII1NCT07709000
Kidney neoplasmII1NCT05842044
Lung neoplasmII1NCT06788912
NeoplasmII1NCT07785609
Patent ductus arteriosusII1NCT05340582
Renal colicII1NCT05722782
Residual neoplasmII1NCT01059786

Everything on Acetaminophen

In Phuturdex you get every trial with sponsors, countries and dates, development events, FDA and EMA approvals, patents and exclusivities, orphan designations and safety alerts, with PDF and Excel export. Free until 31 March 2027.

Open in Phuturdex →

Source: Phuturdex analysis of ClinicalTrials.gov (U.S. National Library of Medicine), FDA and EMA data, updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III. Diseases are those named by each trial (NLM MeSH terms). The estimated launch, when shown, is a Phuturdex calculation described on the Method page, not official data.

ItalianoFrançaisDeutsch